JARDIANCE MET 12.5MG/1000MG – 10 TABLETS
JARDIANCE MET 12.5 MG/1000 MG is a combination medication designed for managing Type 2 diabetes mellitus. It combines empagliflozin and metformin to enhance blood sugar control and support comprehensive diabetes management.
Due to the US administration recent actions on postal shipments we have had to halt Card payment for USA, you can still use Echeck for USA. AUS, UK and other countries can still use card payment. We hope to allow card payments back to USA customers shortly. If you have any questions, please email us at order@aipctshop.info
From wars to politics to daily life — we’ve lost our way. It’s time to return to common sense.
15% off on all product *minimum spend 35$USD, use code : COMMONSENSE15 starts from 16th – 25th September 2025
Description
JARDIANCE MET 12.5 MG/1000 MG contains empagliflozin, an SGLT2 inhibitor, and metformin, a biguanide. Empagliflozin works by preventing glucose reabsorption in the kidneys, leading to its excretion through urine. Metformin improves insulin sensitivity and decreases hepatic glucose production. Together, these medications provide an effective solution for controlling blood glucose levels and managing Type 2 diabetes.
Usage Instructions
Dosage: Take JARDIANCE MET 12.5 MG/1000 MG exactly as prescribed by your healthcare provider.
Administration: Swallow the tablet whole with a glass of water. Do not crush or chew.
Frequency: Typically taken twice daily with meals to minimize gastrointestinal side effects.
Consistency: Take at the same times each day to ensure stable blood glucose levels.
Medicinal Advantages
JARDIANCE MET 12.5 MG/1000 MG offers several benefits:
Dual Action: Combines empagliflozin and metformin for enhanced blood glucose control.
Improved Glucose Excretion: Empagliflozin promotes glucose elimination via urine.
Enhanced Insulin Sensitivity: Metformin improves insulin sensitivity and reduces glucose production from the liver.
Mechanism of Action
JARDIANCE MET 12.5 MG/1000 MG works through its two components:
Empagliflozin: Inhibits SGLT2 (sodium-glucose co-transporter 2), reducing glucose reabsorption in the kidneys and increasing urinary glucose excretion.
Metformin: Decreases glucose production in the liver and enhances the body’s sensitivity to insulin, leading to improved glucose control.
Off-Label Uses
JARDIANCE MET 12.5 MG/1000 MG is primarily prescribed for managing Type 2 diabetes mellitus. Any off-label uses should be discussed with a healthcare provider.
Expert Advice
For optimal diabetes management, take JARDIANCE MET 12.5 MG/1000 MG as directed and combine it with lifestyle changes such as a balanced diet and regular exercise. Regularly monitor your blood glucose levels and consult your healthcare provider for any necessary adjustments to your treatment plan.
Precautions
Kidney Function: Monitor kidney function regularly, as empagliflozin can impact renal health.
Blood Sugar Monitoring: Regularly check your blood glucose levels to avoid hypoglycemia or hyperglycemia.
Drug Interactions: Inform your healthcare provider about all other medications and supplements you are taking to avoid potential interactions.
Storage Conditions
Store JARDIANCE MET 12.5 MG/1000 MG at room temperature, away from moisture and heat. Keep the tablets in their original packaging and out of reach of children.
FAQs
Q: What is JARDIANCE MET 12.5 MG/1000 MG used for? A: JARDIANCE MET 12.5 MG/1000 MG is used to manage Type 2 diabetes mellitus by combining empagliflozin and metformin to effectively control blood glucose levels.
Q: How should I take JARDIANCE MET 12.5 MG/1000 MG? A: Swallow the tablet whole with a glass of water, typically twice daily with meals.
Q: What should I do if I miss a dose of JARDIANCE MET 12.5 MG/1000 MG? A: Take the missed dose as soon as you remember. If it’s almost time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at once.
Additional information
| Weight | 30 g |
|---|---|
| Dosage Type | tablet |
